At Xenome, partnering is an essential component of our corporate strategy. We are committed to identifying the best partners for our suite of products and technologies.

Currently we are seeking partners interested in accessing our unique, venom-based peptide libraries (xdiscover™ and xventure™) for screening against therapeutic targets of interest.

Please click on the links below to download an overview of the discovery and development programs at Xenome:

Peptide Libraries Click here to download further information on the Peptide Library programs at Xenome

Xen2174 Click here to download further information on the Xen2174 program at Xenome

xventure™ Click here to download further information on the xventure™ library at Xenome

Companies interested in partnering with Xenome should contact:

Michael Aldridge - Executive Director
email: michael.aldridge@xenome.com
ph: + 61 7 3720 8055
mob: + 1 650 452 4684